No Evidence to Back Up India’s Best-Selling Diabetes Drugs

Share this post

Millions of patients with type 2 diabetes in India may be at risk because of the widespread use of fixed-dose combinations that do not have sufficient clinical evidence to support their approval, warn researchers.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply